Intrinsiqs

Is Ginkgo Bioworks Holdings, Inc. overvalued?

Ginkgo Bioworks Holdings, Inc. (DNA) — key valuation metrics and fundamentals.

No verdict
Price
$9.61
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$636.7M
Dividend yield
0.0%
Return on equity
-56.9%
Sector
Healthcare

See the full interactive analysis →

Fair value compares DNA's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.